# From the ASPREE investigators: Response to Wittes et al

**Authors:** John J McNeil, Andrew M Tonkin, Anne B Newman, Jeff D Williamson, Robyn L Woods, Andrew T Chan, Geoffrey A Donnan, Christopher M Reid, Mark R Nelson, Sara E Espinoza, Walter P Abhayaratna, Raj C Shah, Peter Gibbs, Michael E Ernst, Nigel P Stocks, Lawrence J Beilin, Brenda Kirpach, Joanne Ryan, Rory Wolfe, Anne M Murray, Karen L Margolis

PMC · DOI: 10.1177/17407745251344560 · Clinical Trials (London, England) · 2025-07-06

## Full-text entities

- **Diseases:** intracranial haemorrhage (MESH:D013345), falls (MESH:C537863), Cancer (MESH:D009369), bleeding (MESH:D006470), Stroke (MESH:D020521), physical disability (MESH:D059445), dementia (MESH:D003704), cardiovascular disease (MESH:D002318), ORCID iDs (MESH:C535742), anaemia (MESH:D000743)
- **Chemicals:** aspirin (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12318158/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12318158/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12318158/full.md

---
Source: https://tomesphere.com/paper/PMC12318158